During the past decade, CHR Metz-Thionville conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 3 clinical trials were completed, i.e. on average, 4.6% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 2 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHR Metz-Thionville" #1 sponsor was "Centre Hospitalier Régional Metz-Thionville" with 40 trials, followed by "UNICANCER" with 4 trials sponsored, "Centre Hospitalier Universitaire Dijon" with 3 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored and "French Innovative Leukemia Organisation" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHR Metz-Thionville" #1 collaborator was "Central Hospital, Nancy, France" with 4 trials as a collaborator, "University of Lorraine" with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "CHR Metz-Thionville" are "Breast Cancer" (5 trials), "Melanoma (Skin)" (3 trials), "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials) and "Covid19" (2 trials). Many other conditions were trialed in "CHR Metz-Thionville" in a lesser frequency.

Most popular intervention types in "CHR Metz-Thionville" are "Drug" (26 trials), "Other" (16 trials), "Procedure" (9 trials), "Biological" (7 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (3 trials), "fluorouracil" (3 trials), "radiation therapy" (3 trials), "Brentuximab Vedotin" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "CHR Metz-Thionville" are 76 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "CHR Metz-Thionville". 2 are not yet recruiting, 14 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in CHR Metz-Thionville, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in CHR Metz-Thionville, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 22 trials that are defined as “Not Applicable".

CHR Metz-Thionville has several departments that took part in Clinical trials: "Service de cardiologie, CHR Metz Thionville" - 2 trials